nach oben

Lung

Erschienen in:

18.08.2018 | ACUTE LUNG INJURY

Inflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome

verfasst von: Mahesh Manjunath Gouda, Sadiya B. Shaikh, Yashodhar Prabhakar Bhandary

Erschienen in: Lung | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Acute respiratory distress syndrome (ARDS) is the most advanced form of acute lung injury (ALI). This is characterized by bilateral pulmonary infiltrates and severe hypoxemia. According to Berlin definition of ARDS, this is defined based on the timings, radiographic changes, edema formation, and severity on the PaO₂/FiO₂ ratio. During ARDS, the loss of integrity of the epithelium causes the septic shock. The degree of epithelial injury is the major prognostic marker of ARDS. In addition to this, inflammatory cell migration, fibro-proliferation, and activation of apoptosis also play an important role in the pathophysiology of ARDS. The alveolar epithelial cell is the prime target during injury where this cell either undergo apoptosis or epithelial–mesenchymal transition (EMT). Injury to the AECs triggers the changes in the DNA fragmentation and activation of certain apoptotic markers such as caspases at the same time some cells undergo biochemical changes and loses its epithelial morphology as well epithelial biomarkers and gain mesenchymal biomarkers and morphology. In both the cases, the fibrinolytic system plays an important role in maintaining the integrity of the disease process efficiently. This review highlights the research evidence of apoptosis and EMT in lung development, injury and its prognosis in ARDS thereby to develop an effective strategy for the treatment of ARDS.

Matthay MA, Zemans RL (2011) The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol Mech Dis 6:147–163. https://doi.org/10.1146/annurev-pathol-011110-130158 CrossRef

Galani V, Tatsaki E, Bai M, Kitsoulis P, Lekka M, Nakos G, Kanavaros P (2010) The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (ARDS): an up-to-date cell-specific review. Pathol Res Pract 206:145–150. https://doi.org/10.1016/j.prp.2009.12.002 CrossRefPubMed

Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349. https://doi.org/10.1056/NEJM200005043421806 CrossRefPubMed

Wiener-Kronish JP, Albertine KH, Matthay MA (1991) Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 88:864–875. https://doi.org/10.1172/JCI115388 CrossRefPubMedPubMedCentral

Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP (1999) Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 104:743–750. https://doi.org/10.1172/JCI7124 CrossRefPubMedPubMedCentral

Matthay MA, Uchida T, Fang X (2002) Clinical acute lung injury and acute respiratory distress syndrome. Curr Treat Options Cardiovasc Med 4:139–149. https://doi.org/10.1007/s11936-002-0034-0 CrossRefPubMed

Shetty S, Padijnayayveetil J, Tucker T, Stankowska D, Idell S (2008) The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability. Am J Physiol Lung Cell Mol Physiol 295:967–975. https://doi.org/10.1152/ajplung.90349.2008 CrossRef

Bhandary YP, Shetty SK, Marudamuthu AS, Ji HL, Neuenschwander PF, Boggaram V, Morris GF, Fu J, Idell S, Shetty S (2013) Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. Am J Pathol 183:131–143. https://doi.org/10.1016/j.ajpath.2013.03.022 CrossRefPubMedPubMedCentral

Bhandary YP, Shetty SK, Marudamuthu AS, Gyetko MR, Idell S, Gharaee-Kermani M, Shetty RS, Starcher BC, Shetty S (2011) Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. Am J Physiol Lung Cell Mol Physiol 302:463–473. https://doi.org/10.1152/ajplung.00099.2011 CrossRef

10.

Han S, Mallampalli RK (2015) The acute respiratory distress syndrome: From mechanism to translation. J Immunol 194:855–860CrossRefPubMed

11.

Watanabe R, Wada H, Watanabe Y, Sakakura M, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Nobori T, Shiku H (2001) Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation. Thromb Res 104:1–6CrossRefPubMed

12.

Marudamuthu AS, Bhandary YP, Shetty SK, Gyetko MR, Idell S, Gharaee-Kermani M, Shetty RS, Starcher BC, Shetty S (2015) Role of the urokinase-fibrinolytic system in epithelial–mesenchymal transition during lung injury. Am J Pathol 185:55–68. https://doi.org/10.1016/j.ajpath.2014.08.027 CrossRefPubMedPubMedCentral

13.

Sakthivel KM, Hariharan S (2017) Regulatory players of DNA damage repair mechanisms: role in cancer chemoresistance. Biomed Pharmacother 93:1238–12345. https://doi.org/10.1016/j.biopha.2017.07.035 CrossRefPubMed

14.

Mello SS, Attardi LD (2018) Deciphering p53 signaling in tumor suppression. Curr Opin Cell Biol 51:65–72. https://doi.org/10.1016/j.ceb.2017.11.005 CrossRefPubMed

15.

Marudamuthu AS, Shetty SK, Bhandary YP, Karandashova S, Thompson M, Sathish V, Florova G, Hogan TB, Pabelick CM, Prakash YS, Tsukasaki Y (2015) Plasminogen activator inhibitor-1 suppresses pro-fibrotic responses in fibroblasts from fibrotic lungs. J Biol Chem 290:9428–9441. https://doi.org/10.1074/jbc.M114.601815 CrossRefPubMedPubMedCentral

16.

Rubenfeld GD (2003) Epidemiology of acute lung injury. Crit Care Med 31:276–284. https://doi.org/10.1097/01.CCM.0000057904.62683.2B CrossRef

17.

Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353:1685. https://doi.org/10.1056/NEJMoa050333 CrossRefPubMed

18.

MacCallum NS, Evans TW (2005) Epidemiology of acute lung injury. Curr Opin Crit Care 11:43CrossRefPubMed

19.

Estenssoro E, Dubin A, Laffaire E, Canales H, Sáenz G, Moseinco M, Pozo M, Gómez A, Baredes N, Jannello G, Osatnik J (2002) Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med 30:2450. https://doi.org/10.1097/01.CCM.0000034692.46267.02 CrossRefPubMed

20.

Brower RG, Lanken PN, MacIntyre N (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327. https://doi.org/10.1056/NEJMoa032193 CrossRefPubMed

21.

Villar J, Blanco J, Añón JM, Santos-Bouza A, Blanch L, Ambrós A, Gandía F, Carriedo D, Mosteiro F, Basaldúa S, Fernández RL (2011) The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensiv Care Med 37:1932. https://doi.org/10.1007/s00134-011-2380-4 CrossRef

22.

Es Esteban A, Frutos-Vivar F, Muriel A, Ferguson ND, Peñuelas O, Abraira V, Raymondos K, Rios F, Nin N, Apezteguía C, Violi DA (2013) Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med 188:220CrossRef

23.

Wang CY, Calfee CS, Paul DW, Janz DR, May AK, Zhuo H, Bernard GR, Matthay MA, Ware LB, Kangelaris KN (2014) One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome. Intensiv Care Med 40:388. https://doi.org/10.1164/rccm.201212-2169OC CrossRef

24.

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, Van Haren F, Larsson A, McAuley DF, Ranieri M (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788. https://doi.org/10.1001/jama.2016.0291 CrossRefPubMed

25.

Siegel MD, Parsons PE, Finlay G (2016) Acute respiratory distress syndrome: prognosis and outcomes in adults. UpToDate

26.

Montgomery AB, Stager MA, Carrico CJ, Hudson LD (1985) Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132:485. https://doi.org/10.1164/arrd.1985.132.3.485 CrossRefPubMed

27.

Bersten AD, Edibam C, Hunt T, Moran J, Group TA (2002) Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. Am J Respir Crit Care Med 165:443–448. https://doi.org/10.1164/ajrccm.165.4.2101124 CrossRefPubMed

28.

Ricard JD, Dreyfuss D, Saumon G (2001) Production of inflammatory cytokines in ventilator-induced lung injury: a reappraisal. Am J Respir Crit Care Med 163:1176–1180. https://doi.org/10.1164/ajrccm.163.5.2006053 CrossRefPubMed

29.

Shaikh P (2011) Cytokines and their physiologic and pharmacologic functions in inflammation: a review. Int J Pharm Life Sci 11:1247–1263

30.

Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM (1991) Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem 266:9912–9918PubMed

31.

Selman M, Pardo A (2006) Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc 3:364–372. https://doi.org/10.1513/pats.200601-003TK CrossRefPubMed

32.

Crimi E, Slutsky AS (2004) Inflammation and the acute respiratory distress syndrome. Best Pract Res Clin Anaesthesiol 18:477–492. https://doi.org/10.1016/j.bpa.2003.12.007 CrossRefPubMed

33.

Gasse P, Riteau N, Vacher R, Michel ML, Fautrel A, Di Padova F, Fick L, Charron S, Lagente V, Eberl G, Le Bert M (2011) IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS ONE 6:23185. https://doi.org/10.1371/journal.pone.0023185 CrossRef

34.

Ge S, Hertel B, Susnik N, Rong S, Dittrich AM, Schmitt R, Haller H, von Vietinghoff S (2014) Interleukin 17 receptor A modulates monocyte subsets and macrophage generation in vivo. PLoS ONE 9:1–10. https://doi.org/10.1371/journal.pone.0085461 CrossRef

35.

Cheng DS, Han W, Chen SM, Sherrill TP, Chont M, Park GY, Sheller JR, Polosukhin VV, Christman JW, Yull FE, Blackwell TS (2007) Airway epithelium controls lung inflammation and injury through the NF-κB pathway. J Immunol 178:6504–6513. https://doi.org/10.4049/jimmunol.178.10.6504 CrossRefPubMed

36.

Gouda MM, Prabhu A, Bhandary YP (2017) Curcumin alleviates IL-17A-mediated p53-PAI-1 expression in bleomycin-induced alveolar basal epithelial cells. J Cell Biochem 119:2222–2230. https://doi.org/10.1002/jcb.26384 CrossRefPubMed

37.

Coffill CR, Lee AP, Siau JW (2016) The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans. Genes Dev 30:281–292. https://doi.org/10.1101/gad.274118.115 CrossRefPubMedPubMedCentral

38.

Luce JM (1998) Acute lung injury and the acute respiratory distress syndrome. Crit Care Med 26:369–376CrossRefPubMed

39.

Cheng IW, Matthay MA (2003) Acute lung injury and the acute respiratory distress syndrome. Crit Care Clin 19:693–712. https://doi.org/10.1016/j.ccc.2004.05.010 CrossRefPubMed

40.

Wheeler AP, Bernard GR (2007) Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 369:1553–1564. https://doi.org/10.1016/S0140-6736(07)60604-7 CrossRefPubMed

41.

Matthay MA, Zimmerman GA (2005) Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 33:319–327. https://doi.org/10.1165/rcmb.F305 CrossRefPubMedPubMedCentral

42.

Staub NC (1981) Pulmonary edema due to increased microvascular permeability. Annu Rev Med 32:291–312CrossRefPubMed

43.

Crosby LM, Waters CM (2010) Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 298:715–731. https://doi.org/10.1152/ajplung.00361.2009 CrossRef

44.

Matthay MA, Ware LB, Zimmerman GA (2012)The acute respiratory distress syndrome. J Clin Investig 122:2731. https://doi.org/10.1172/JCI60331 CrossRefPubMedPubMedCentral

45.

Kasper M, Barth K (2017) Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis. Biosci Rep 37:6. https://doi.org/10.1042/BSR20171301 CrossRef

46.

Matthay MA, Wiener-Kronish P (1990) Intact epithelial barrier function is critical for the resolution of alveolar edema in humans1-3. Am Rev Respir Dis 142:1250–1257CrossRefPubMed

47.

48.

Su X, Johansen M, Looney MR, Brown EJ, Matthay MA (2008) CD47 deficiency protects mice from lipopolysaccharide-induced acute lung injury and Escherichia coli pneumonia. J Immunol 180:6947–6953. https://doi.org/10.4049/jimmunol.180.10.6947 CrossRefPubMed

49.

Zemans RL, Colgan SP, Downey GP (2009) Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol 40:519–535. https://doi.org/10.1165/rcmb.2008-0348TR CrossRefPubMed

50.

Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, Lee PJ (2006) Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 12:1286–1293. https://doi.org/10.1038/nm1494 CrossRefPubMedPubMedCentral

51.

Bachofen M, Weibel ER (1977) Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 116:589–615. https://doi.org/10.1164/arrd.1977.116.4.589 CrossRefPubMed

52.

Bardales RH, Xie SS, Schaefer RF, Hsu SM. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 149: 845–852

53.

Guinee D Jr, Brambilla E, Fleming M, Hayashi T, Rahn M, Koss M, Ferrans V, Travis W (1997) The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am J Pathol 151:999–1007PubMedPubMedCentral

54.

Lee WL, Downey GP (2001) Neutrophil activation and acute lung injury. Curr Opin Crit Care 7:1–7CrossRefPubMed

55.

Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T, Maeyama T, Hara N (2000) Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am J Pathol 157:597–603. https://doi.org/10.1016/S0002-9440(10)64570-1 CrossRefPubMedPubMedCentral

56.

Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA, Ware LB (2002) Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161:1783–1796. https://doi.org/10.1016/S0002-9440(10)64455-0 CrossRefPubMedPubMedCentral

57.

Tanaka M, Itai T, Adachi M, Nagata S (1998) Downregulation of Fas ligand by shedding. Nat Med 4:31–36. https://doi.org/10.1038/nm0198-031 CrossRefPubMed

58.

Fine AL, Anderson NL, Rothstein TL, Williams MC, Gochuico BR (1997) Fas expression in pulmonary alveolar type II cells. Am J Physiol 273:L64–L71. https://doi.org/10.1152/ajplung.1997.273.1.L64 CrossRefPubMed

59.

Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR, Liles WC (2001) Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol 158:153–161. https://doi.org/10.1016/S0002-9440(10)63953-3 CrossRefPubMedPubMedCentral

60.

Martin TR, Nakamura M, Matute-Bello G (2003) The role of apoptosis in acute lung injury. Crit Care Med 31:S184–S188. https://doi.org/10.1097/01.CCM.0000057841.33876.B1 CrossRefPubMed

61.

Hay J, Shahzeidi S, Laurent G (1991) Mechanisms of bleomycin-induced lung damage. Arch Toxicol 65:81–94CrossRefPubMed

62.

Hagimoto N, Kuwano K, Kawasaki M, Yoshimi M, Kaneko Y, Kunitake R, Maeyama T, Tanaka T, Hara N (1999) Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by fas ligation. Am J Respir Cell Mol Biol 21:436–445. https://doi.org/10.1165/ajrcmb.21.3.3397 CrossRefPubMed

63.

Kalluri R, Neilson EG (2003) Epithelial mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776–1784. https://doi.org/10.1172/JCI20530 CrossRefPubMedPubMedCentral

64.

Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429–1437. https://doi.org/10.1172/JCI36183 CrossRefPubMedPubMedCentral

65.

Potenta S, Zeisberg EG, Kalluri R (2008) The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 99:1375–1379. https://doi.org/10.1038/sj.bjc.6604662 CrossRefPubMedPubMedCentral

66.

Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952–961. https://doi.org/10.1038/nm1613 CrossRefPubMed

67.

Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282:23337–23347. https://doi.org/10.1074/jbc.M700194200 CrossRefPubMed

68.

Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103:13180–13185. https://doi.org/10.1073/pnas.0605669103 CrossRefPubMedPubMedCentral

69.

Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14:818–829. https://doi.org/10.1016/j.devcel.2008.05.009 CrossRefPubMed

70.

Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442–454. https://doi.org/10.1038/nrc822 CrossRefPubMed

71.

Fidler IJ, Poste G (2008) The “seed and soil” hypothesis revisited. Lancet Oncol 9:808. https://doi.org/10.1016/S1470-2045(08)70201-8 CrossRefPubMed

72.

Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T(2001) Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 98:10356–10361. https://doi.org/10.1073/pnas.171610498 CrossRefPubMedPubMedCentral

73.

Heise RL, Stober V, Cheluvaraju C, Hollingsworth JW, Garantziotis S (2011) Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity. J Biol Chem 286:17435–17444. https://doi.org/10.1074/jbc.M110.137273 CrossRefPubMedPubMedCentral

74.

Li LF, Liu YY, Kao KC, Wu CT, Chang CH, Hung CY, Yang CT (2014) Mechanical ventilation augments bleomycin-induced epithelial-mesenchymal transition through the Src pathway. Lab Invest 94:1017–1029. https://doi.org/10.1038/labinvest.2014.75 CrossRefPubMed

75.

Li LF, Lee CS, Lin CW, Chen NH, Chuang LP, Hung CY, Liu YY (2017) Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway. PLoS ONE 12:0172571. https://doi.org/10.1371/journal.pone.0172571 CrossRef

76.

Chen Q, Luo AA, Qiu H, Han B, Ko BH, Slutsky AS, Zhang H (2014) Monocyte interaction accelerates HCl-induced lung epithelial remodeling. BMC Pulm Med 14:135. https://doi.org/10.1186/1471-2466-14-135 CrossRefPubMedPubMedCentral

77.

Zhang YQ, Liu YJ, Mao YF, Dong WW, Zhu XY, Jiang L (2015) Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling. Clin Nutr 34:752–760. https://doi.org/10.1016/j.clnu.2014.08.014 CrossRefPubMed

78.

Feng Z, Zhang H, Levine AJ, Jin S (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102:8204–8209. https://doi.org/10.1073/pnas.0502857102 CrossRefPubMedPubMedCentral

79.

Wang Z, Jiang Y, Guan D, Li J, Yin H, Pan Y, Xie D, Chen Y (2013) Critical roles of p53 in epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma cells. PLoS ONE 8:72846. https://doi.org/10.1371/journal.pone.0072846 CrossRef

80.

Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M (2011) p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13:317CrossRefPubMedPubMedCentral

81.

Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med 353:1711–1723CrossRefPubMed

82.

Nakayama S, Yokote T, Kobayashi K, Hirata Y, Akioka T, Hara S, Miyoshi T, Takubo T, Tsuji M, Hanafusa T (2008) Successful therapy with high-dose steroids and cyclosporin in lenograstim-induced acute respiratory distress syndrome. Respir Med CME 1:188–192CrossRef

Titel: Inflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome
verfasst von: Mahesh Manjunath Gouda
Sadiya B. Shaikh
Yashodhar Prabhakar Bhandary
Publikationsdatum: 18.08.2018
Verlag: Springer US
Erschienen in: Lung / Ausgabe 5/2018
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-018-0150-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Inflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Dasatinib Suppresses TGFβ-Mediated Epithelial–Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis

Esophageal Lung in Association with Pulmonary Vascular Anomalies

Changes in the Burden of Comorbidities in Patients with COPD and Asthma–COPD Overlap According to the GOLD 2017 Recommendations

Strategies for the Integration of Cough and Swallow to Maintain Airway Protection in Humans

Ventilator Weaning and Excursion Time Index: One Step Closer to the Quantum Leap?

Ventilator Weaning: How Far from the Final Quantum Leap?

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin